Influenza vaccines: cost-effectiveness in older adults

Home Influenza vaccines: cost-effectiveness in older adults

    Systematic review on the cost-effectiveness of seasonal influenza vaccines in older adults

     

    Commissioner: Public Health Agency of Canada (PHAC)

    Funder: Canadian Institutes of Health Research (CIHR) through the Drug Safety and Effectiveness Network (DSEN)

    Share Buttons

    [ssba-buttons]
    • To provide a comparison of the cost-effectiveness of different seasonal influenza vaccines in older adults (≥65 years of age)

     

    Category :

    Date : 15 Jan 2021

    Copyright © 2019 Knowledge Translation Program